Author: Rheamitra

Staff at the Women’s Health Center of West Virginia are intimately familiar with the challenges of delivering essential healthcare services, even in the face of contentious debates and attempts by government officials to impose limitations. For years, the Charleston clinic stood as the sole abortion provider in the state until a recent legislative move by the state Legislature resulted in an almost complete prohibition of the procedure. Despite these changes, the clinic continued its operations, extending crucial reproductive healthcare services beyond abortions. Presently, the clinic is actively pursuing the establishment of a syringe service program to support individuals struggling with…

During the Fourth of July weekend, Ashley Summers, a 35-year-old mother of two from Indiana, experienced a severe sense of dehydration while enjoying time at Lake Freeman with her family. Despite her efforts to stay hydrated, she found it difficult to quench her thirst. In an attempt to alleviate her discomfort, Ashley consumed an unusually large quantity of water within a brief period. Tragically, this led to her collapse and eventual passing due to water toxicity, an uncommon but serious outcome resulting from excessive and rapid water intake. According to her brother Devon Miller, as reported by New York Post,…

Union Health Minister Mansukh Mandaviya announced on Wednesday that Pharmaceutical companies with an annual turnover exceeding ₹ 250 crore will be required to implement Good Manufacturing Practices (GMP) within the next six months. As per the announcement, pharmaceutical companies having an annual turnover of less than ₹ 250 crore will be given a 12-month period to implement Good Manufacturing Practices (GMP). Those who do not comply with the given timeline may face penalties as per the legal provisions.  The implementation of GMP guidelines is crucial to ensure the quality and safety of pharmaceutical products in India, and failure to comply…

The U.S. State Department has established a new bureau on Tuesday with the objective of ensuring that combating global outbreaks remains a sustained priority of U.S. foreign policy. However, this effort comes at a time when one of its successful initiatives, an HIV program, is embroiled in a political dispute over abortion. As part of the new bureau, the President’s Emergency Program for AIDS Relief (PEPFAR), a 20-year-old initiative, will be included. While not widely known among Americans, PEPFAR has exceeded most initial expectations in its efforts to combat the AIDS crisis and is recognized for saving as many as…

On Monday, the US National Institute of Health(NIH) announced the initiation of mid-stage clinical trials aimed at testing several treatments for patients experiencing symptoms of long covid. Among the treatments being studied is Pfizer’s Paxlovid, along with at least three other treatments. The objective of the trials is to assess the safety and efficacy of the treatments in managing the symptoms of long COVID, which refers to the persisting symptoms experienced by patients even after recuperating from the initial phase of COVID-19. The first part of the trial will specifically focus on testing a longer dosing regimen of Pfizer’s antiviral…

The SIPCOT Industrial complex at Oragadam in Kanchipuram District is gearing up to set up a 350-acre medical devices park that has the potential to attract investments worth 350 crore. Moreover, a pharma park is also under development in Tindivanam in Villupuram district, which is expected to produce drugs and pharmaceutical products worth 200 crore annually.  The pharmaceutical industry in Tamil Nadu is optimistic that the state can attract investments of up to 10 billion dollars, given that the Indian pharma industry’s size is projected to reach 130 billion dollars. It is noteworthy that over a century ago, the Madras…

Novo Nordisk has launched its popular weight-loss drug, Wegovy, in Germany, marking its entry into a significant European market. The company is banking on the drug’s success and is anticipating that Germans will be willing to pay several hundred euros out of their own pockets for it since public health insurance policies do not currently cover it. The weight-loss medication, Wegovy, has been proven to assist individuals in shedding roughly 15% of their body weight when combined with exercise and lifestyle modifications. The drug is currently available in the United States, but it has only been introduced in small Norwegian…

According to recent research, the incidence of alpha-gal syndrome, a rare meat allergy caused by tick bites, is on the rise in the United States. The Centers for Disease Control and Prevention (CDC) have reported that an increasing number of people are developing this allergy, which can lead to severe reactions to various types of meat and animal products, potentially posing a threat to life. It is estimated that up to 450,000 Americans may have already been affected by this condition. Experts have cautioned that the geographic range of ticks, which can be identified by the distinctive white spot on…

Lupin specializes in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products, including both generic and branded medications, biosimilars, and specialty products. The company has a significant presence in the U.S., Europe, and Asia and operates in more than 100 countries. Lupin’s product portfolio includes a wide range of medications, including those used to treat cardiovascular disease, diabetes, oncology, respiratory disorders, and women’s health issues. The company has also developed and commercialized several first-to-file and first-to-market generic drugs. Lupin’s Australia-based unit has received approval to market a medication for the management of chronic obstructive pulmonary disease…

According to a federal lawsuit filed in Sacramento, California, health insurance provider Cigna has been accused of violating California law by using a computer algorithm to automatically reject hundreds of thousands of patient claims without proper individual examination. The lawsuit claims that Cigna’s use of this algorithm has resulted in the wrongful denial of coverage for many patients. A class-action lawsuit was filed on Monday in federal court in Sacramento, alleging that Cigna Corp. and Cigna Health and Life Insurance Co. automatically denied over 300,000 payment claims in a span of just two months in 2022. The lawsuit implies that…